The fungal debate: Where do we stand today?

Rhinology

Volumn 45, Issue 3, 2007, Pages 178-189

  Ebbens, F A ^a   Georgalas, C ^a,b   Rinia, A B ^a   van Drunen, C M ^a   Lund, Valerie J ^b   Fokkens, W J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NATIONAL THROAT NOSE AND EAR HOSPITAL   (United Kingdom)

Author keywords

Antifungal treatment; Chronic rhinosinusitis; Eosinophils; Fungi; Nasal polyps

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; IMMUNOGLOBULIN G;

CELLULAR IMMUNITY; EOSINOPHILIA; HUMAN; IMMUNOLOGY; LABORATORY DIAGNOSIS; MICROBIOLOGY; NOSE MUCOSA; REVIEW; RHINITIS; SINUSITIS; T LYMPHOCYTE; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; EOSINOPHILIA; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; NASAL MUCOSA; RHINITIS; SINUSITIS; SPECIMEN HANDLING; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 35148863017     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2007. Rhinol Suppl 20; 2007; 45: 1-139.
2. deShazo RD, Chapin V., Swain RE. Fungal sinusitis. N Engl J Med 1997; 337: 254-259.
3. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74: 877-884.
4. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72: 89-93.
5. Robson JM, Hogan PG, Benn RA, Gatenby PA. Allergic fungal sinusitis presenting as a paranasal sinus tumour. Aust N Z J Med 1989; 19: 351-353.
6. Bent JP, III, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111: 580-588.
7. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96: 24-35.
8. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinico-pathological entity. Laryngoscope 2000; 110: 799-813.
9. Catten MD, Murr AH, Goldstein JA, Mhatre AN, Lalwani AK. Detection of fungi in the nasal mucosa using polymerase chain reaction. Laryngoscope 2001; 111: 399-403.
10. Rao AK, Mathers PH, Ramadan HH. Detection of fungi in the sinus mucosa using polymerase chain reaction. Otolaryngol Head Neck Surg 2006; 134: 581-585.
11. Polzehl D, Weschta M, Podbielski A, Riechelmann H, Rimek D. Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis. J Med Microbiol 2005; 54: 31-37.
12. Kostamo K, Richardson M, Virolainen-Julkunen A, Leivo I, Malmberg H, Ylikoski J et al. Microbiology of chronic hyperplastic sinusitis. Rhinology 2004; 42: 213-218.
13. Granville L, Chirala M, Cernoch P, Ostrowski M, Truong LD. Fungal sinusitis: histologic spectrum and correlation with culture. Hum Pathol 2004; 35: 474-481.
14. Jiang RS, Su MC, Lin JF. Nasal mycology of chronic rhinosinusitis. Am J Rhinol 2005; 19: 131-133.
15. Scheuller MC, Murr AH, Goldberg AN, Mhatre AN, Lalwani AK. Quantitative analysis of fungal DNA in chronic rhinosinusitis. Laryngoscope 2004; 114: 467-471.
16. Kim ST, Choi JH, Jeon HG, Cha HE, Hwang YJ, Chung YS. Comparison between polymerase chain reaction and fungal culture for the detection of fungi in patients with chronic sinusitis and normal controls. Acta Otolaryngol 2005; 125: 72-75.
17. Murr AH, Goldberg AN, Vesper S. Fungal speciation using quantitative polymerase chain reaction (QPCR) in patients with and without chronic rhinosinusitis. Laryngoscope 2006; 116: 1342-1348.
18. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004; 113: 1122-1128.
19. Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, Kephart G et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002; 127: 377-383.
20. Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. 'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope 2003; 113: 264-269.
21. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, Warsi G et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005; 115: 1793-1799.
22. Corradini C, Del NM, Buonomo A, Nucera E, Paludetti G, Alonzi C et al. Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 2006; 16: 188-193.
23. Buzina W, Braun H, Freudenschuss K, Lackner A, Habermann W, Stammberger H. Fungal biodiversity-as found in nasal mucus. Med Mycol 2003; 41: 149-161.
24. Gosepath J, Brieger J, Vlachtsis K, Mann WJ. Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 2004; 18: 9-13.
25. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005; 115: 125-131.
26. Ragab A, Clement P, Vincken W, Nolard N, Simones F. Fungal cultures of different parts of the upper and lower airways in chronic rhinosinusitis. Rhinology 2006; 44: 19-25.
27. Lackner A, Stammberger H, Buzina W, Freudenschuss K, Panzitt T, Schosteritsch S et al. Fungi: a normal content of human nasal mucus. Am J Rhinol 2005; 19: 125-129.
28. Ferguson BJ, Barnes L, Bernstein JM, Brown D, Clark CE, III, Cook PR et al. Geographic variation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am 2000; 33: 441-449.
29. Faure O, Fricker-Hidalgo H, Lebeau B, Mallaret MR, mbroise-Thomas P, Grillot R. Eight-year surveillance of environmental fungal contamination in hospital operating rooms and haematological units. J Hosp Infect 2002; 50: 155-160.
30. Lebowitz RA, Waltzman MN, Jacobs JB, Pearlman A, Tierno PM. Isolation of fungi by standard laboratory methods in patients with chronic rhinosinusitis. Laryngoscope 2002; 112: 2189-2191.
31. Mitakakis TZ, Barnes C, Tovey ER. Spore germination increases allergen release from Alternaria. J Allergy Clin Immunol 2001; 107: 388-390.
32. Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002; 110: 862-866.
33. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006; 118: 1149-1156.
34. Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005; 115: 601-606.
35. Terho E, Frew AJ. Type III allergy skin testing. Position statement for EAACI Subcommittee on Skin Tests and Allergen Standardization. Allergy 1995; 50: 392-396.
36. Shin SH, Ponikau JU, Sherris DA, Congdon D, Frigas E, Homburger HA et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114: 1369-1375.
37. Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun 2007; 75: 1424-1435.
38. Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol 2005; 129: 569-582.
39. Prussin C, Metcalfe DD. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2006; 117(2 Suppl Mini-Primer): S450-S456.
40. Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003; 112: 877-882.
41. Ponikau JU, Sherris DA, Kephart GM, Kern EB, Congdon DJ, Adolphson CR et al. Striking deposition of toxic eosinophil major basic protein in mucus: implications for chronic rhinosinusitis. J Allergy Clin Immunol 2005; 116: 362-369.
42. Wei JL, Kita H, Sherris DA, Kern EB, Weaver A, Ponikau JU. The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 2003; 113: 303-306.
43. Hakansson L, Carlson M, Stalenheim G, Venge P. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma. J Allergy Clin Immunol 1990; 85: 743-750.
44. Griffin E, Hakansson L, Formgren H, Jorgensen K, Venge P. Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients. Allergy 1991; 46: 255-265.
45. Koenderman L, van der BT, Schweizer RC, Warringa RA, Coffer P, Caldenhoven E et al. Eosinophil priming by cytokines: from cellular signal to in vivo modulation. Eur Respir J Suppl 1996; 22: 119s-25s.
46. Borish LC, Steinke JW. 2. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111(2 Suppl): S460-S475.
47. Haselden BM, Syrigou E, Jones M, Huston D, Ichikawa K, Chapman MD et al. Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. J Allergy Clin Immunol 2001; 108: 349-356.
48. Kroegel C, Liu MC, Hubbard WC, Lichtenstein LM, Bochner BS. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. J Allergy Clin Immunol 1994; 93: 725-734.
49. Mahmudi-Azer S, Downey GP, Moqbel R. Translocation of the tetraspanin CD63 in association with human eosinophil mediator release. Blood 2002; 99: 4039-4047.
50. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J Immunol 2005; 175: 5439-5447.
51. Hackett TL, Knight DA. The role of epithelial injury and repair in the origins of asthma. Curr Opin Allergy Clin Immunol 2007; 7: 63-68.
52. Busse W, Elias J, Sheppard D, Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999; 160: 1035-1042.
53. Pawankar R, Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 2007; 7: 202-208.
54. Frigas E, Motojima S, Gleich GJ. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma. Eur Respir J Suppl 1991; 13: 123s-35s.
55. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000; 105: 1185-1193.
56. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004; 114: 997-1008.
57. Fedorov IA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005; 60: 389-394.
58. Bent JP, III, Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 1996; 106: 1331-1334.
59. Wildfeuer A, Seidl HP, Paule I, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998; 41: 309-319.
60. Kfoury AG, Smith JC, Farhoud HH, Terreros DA, Stringham JC, Taylor DO et al. Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient. Clin Transplant 1997; 11: 608-612.
61. Fan-Havard P, O'Donovan C, Smith SM, Oh J, Bamberger M, Eng RH. Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clin Infect Dis 1995; 21: 960-965.
62. Jacobs LG, Skidmore EA, Freeman Y, Lipschultz D, Fox N. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996; 22: 30-35.
63. Leu HS, Huang CT. Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study. Clin Infect Dis 1995; 20: 1152-1157.
64. Bossler AD, Richter SS, Chavez AJ, Vogelgesang SA, Sutton DA, Grooters AM et al. Exophiala oligosperma causing olecranon bursitis. J Clin Microbiol 2003; 41: 4779-4782.
65. Struijk DG, Krediet RT, Boeschoten EW, Rietra PJ, Arisz L. Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1987; 9: 66-70.
66. Bhattacharyya T, Piccirillo J, Wippold FJ. Relationship between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 1997; 123: 1189-1192.
67. Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002; 116: 261-263.
68. Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope 2004; 114: 2224-2227.
69. Rains BM, III, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003; 17: 1-8.
70. Hofer E, Neher A, Schrott-Fischer A, Nagl M. Influence of amphotericin B on the ciliary beat frequency of nasal mucosa. Laryngoscope 2004; 114: 1964-1966.
71. Gosepath J, Grebneva N, Mossikhin S, Mann WJ. Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol 2002; 16: 25-31.
72. Jornot L, Rochat T, Lacroix JS. Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 2003; 41: 201-205.
73. Jornot L, Rochat T, Caruso A, Lacroix JS. Effects of amphotericin B on ion transport proteins in airway epithelial cells. J Cell Physiol 2005; 204: 859-870.
74. Shin SH, Ye MK. Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 2004; 124: 1174-1177.
75. Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006; 132: 743-747.